Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus

References

• Ballard MS, Schonheyder HC, Knudsen JD, Lyytikainen O, Dryden M, Kennedy KJ, Valiquette L, Pinholt M, Jacobsson G, Laupland KB, et al. The changing epidemiology of group B streptococcus bloodstream infection: A multi-national population-based assessment. Infect Dis (Lond). 2016;48(5):386-91. doi:10.3109/23744235.2015.1131330. PMID:26759190
   PubMed Web of Science ®Google Scholar
• Florindo C, Damiao V, Silvestre I, Farinha C, Rodrigues F, Nogueira F, Martins-Pereira F, Castro R, Borrego MJ, Santos-Sanches I, et al. Epidemiological surveillance of colonising group B Streptococcus epidemiology in the Lisbon and Tagus Valley regions, Portugal (2005 to 2012): Emergence of a new epidemic type IV/clonal complex 17 clone. Euro Surveill. 2014;19(23):20. doi:10.2807/1560-7917.ES2014.19.23.20825
   Google Scholar
• Wong SS, Tsui K, Liu QD, Lin LC, Tsai CR, Chen LC, Huang CH. Serotypes, surface proteins, and clinical syndromes of invasive group B streptococcal infections in northern Taiwan, 1998–2009. J Microbiol Immunol Infect. 2011;44(1):8-14. doi:10.1016/j.jmii.2011.01.003. PMID:21531346
   PubMedGoogle Scholar
• Florindo C, Gomes JP, Rato MG, Bernardino L, Spellerberg B, Santos-Sanches I, Borrego MJ. Molecular epidemiology of group B streptococcal meningitis in children beyond the neonatal period from Angola. J Med Microbiol. 2011;60(Pt 9):1276-80. doi:10.1099/jmm.0.031674-0. PMID:21474607
   PubMed Web of Science ®Google Scholar
• Poyart C, Réglier-Poupet H, Tazi A, Billoët A, Dmytruk N, Bidet P, Bingen E, Raymond J, Trieu-Cuot P. Invasive group B streptococcal infections in infants, France. Emerg Infect Dis. 2008;14(10):1647-9. doi:10.3201/eid1410.080185. PMID:18826837
   PubMed Web of Science ®Google Scholar
• Bohnsack JF, Whiting A, Gottschalk M, Dunn DM, Weiss R, Azimi PH, Philips JB 3rd, Weisman LE, Rhoads GG, Lin FY. Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999. J Clin Microbiol. 2008;46(4):1285-91. doi:10.1128/JCM.02105-07. PMID:18287314
   PubMed Web of Science ®Google Scholar
• Johri AK, Paoletti LC, Glaser P, Dua M, Sharma PK, Grandi G, Rappuoli R. Group B Streptococcus: Global incidence and vaccine development. Nat Rev Microbiol. 2006;4(12):932-42. doi:10.1038/nrmicro1552. PMID:17088932
   PubMed Web of Science ®Google Scholar
• Luan SL, Granlund M, Sellin M, Lagergård T, Spratt BG, Norgren M. Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol. 2005;43(8):3727-33. doi:10.1128/JCM.43.8.3727-3733.2005. PMID:16081902
   PubMed Web of Science ®Google Scholar
• Gavino M, Wang E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. Am J Obstet Gynecol. 2007;197(4):388.e381-384. doi:10.1016/j.ajog.2007.06.016. PMID:17904971
   PubMed Web of Science ®Google Scholar
• Seo YS, Srinivasan U, Oh KY, Shin JH, Chae JD, Kim MY, Yang JH, Yoon HR, Miller B, DeBusscher J, et al. Changing molecular epidemiology of group B streptococcus in Korea. J Korean Med Sci. 2010;25(6):817-23. doi:10.3346/jkms.2010.25.6.817. PMID:20514299
   PubMed Web of Science ®Google Scholar
• Yücesoy G, Caliskan E, Karadenizli A, Corakci A, Yucesoy I, Hüseyinoğlu N, Babaoğlu K. Maternal colonisation with group B streptococcus and effectiveness of a culture-based protocol to prevent early-onset neonatal sepsis. Int J Clin Pract. 2004;58(8):735-9. doi:10.1111/j.1368-5031.2004.00025.x. PMID:15372844
   PubMed Web of Science ®Google Scholar
• Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, Heath PT. Group B streptococcal disease in infants aged younger than 3 months: Systematic review and meta-analysis. Lancet. 2012;379(9815):547-56. doi:10.1016/S0140-6736(11)61651-6. PMID:22226047
   PubMed Web of Science ®Google Scholar
• Baker JA, Lewis EL, Byland LM, Bonakdar M, Randis TM, Ratner AJ. Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization. Vaccine. 2017;35(9):1273-80. doi:10.1016/j.vaccine.2017.01.029. PMID:28162823
   PubMed Web of Science ®Google Scholar
• Heath PT. Status of vaccine research and development of vaccines for GBS. Vaccine. 2016;34(26):2876-9. doi:10.1016/j.vaccine.2015.12.072. PMID:26988258
   PubMed Web of Science ®Google Scholar
• Björnsdóttir E, Martins E, Erlendsdóttir H, Haraldsson G, Melo-Cristino J, Kristinsson K, Ramirez M. Changing epidemiology of group B streptococcal infections among adults in Iceland: 1975–2014. Clin Microbiol Infect. 2016;22(4):379.e379-379.e316 doi:10.1016/j.cmi.2015.11.020
   Web of Science ®Google Scholar
• Flores AR, Galloway-Peña J, Sahasrabhojane P, Saldaña M, Yao H, Su X, Ajami NJ, Holder ME, Petrosino JF, Thompson E, et al. Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes. Proc Natl Acad Sci U S A. 2015;112(20):6431-6. doi:10.1073/pnas.1504725112. PMID:25941374
   PubMed Web of Science ®Google Scholar
• Sunkara B, Bheemreddy S, Lorber B, Lephart PR, Hayakawa K, Sobel JD, Kaye KS, Marchaim D. Group B Streptococcus infections in non-pregnant adults: The role of immunosuppression. Int J Infect Dis. 2012;16(3):e182-6. doi:10.1016/j.ijid.2011.11.008. PMID:22236484
   PubMed Web of Science ®Google Scholar
• Ma YY, Hsu TY, Shen SY, Huang TS, Moh JS, Liu CM, Ou CY, Lin H. Epidemiology of group B Streptococcus ST-17 clone in pregnant women of South Taiwan. Gynecol Obstet Invest. 2012;73(4):285-93. doi:10.1159/000334406. PMID:22516869
   PubMed Web of Science ®Google Scholar
• Tazi A, Disson O, Bellais S, Bouaboud A, Dmytruk N, Dramsi S, Mistou MY, Khun H, Mechler C, Tardieux I, et al. The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med. 2010;207(11):2313-22. doi:10.1084/jem.20092594. PMID:20956545
   PubMed Web of Science ®Google Scholar
• Siciliano RF, Cais DP, Navarro RC, Strabelli TM. Acute Streptococcus agalactiae endocarditis: Outcomes of early surgical treatment. Heart Lung. 2010;39(4):331-4. doi:10.1016/j.hrtlng.2009.06.018. PMID:20561837
   PubMed Web of Science ®Google Scholar
• Ivanova Georgieva R, García López MV, Ruiz-Morales J, Martínez-Marcos FJ, Lomas JM, Plata A, Noureddine M, Hidalgo-Tenorio C, Reguera JM, De la Torre Lima J, et al. Streptococcus agalactiae left-sided infective endocarditis. Analysis of 27 cases from a multicentric cohort. J Infect. 2010;61(1):54-59. doi:10.1016/j.jinf.2010.04.005. PMID:20417661
   PubMed Web of Science ®Google Scholar
• Tsui MH, Ip M, Ng PC, Sahota DS, Leung TN, Lau TK. Change in prevalence of group B Streptococcus maternal colonisation in Hong Kong. Hong Kong Med J. 2009;15(6):414-9. PMID:19966344
   PubMedGoogle Scholar
• Desa DJ, Trevenen CL. Intrauterine infections with group B beta-haemolytic streptococci. Br J Obstet Gynaecol. 1984;91(3):237-9. doi:10.1111/j.1471-0528.1984.tb04759.x. PMID:6367810
   PubMedGoogle Scholar
• Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA. 2008;299(17):2056-65. doi:10.1001/jama.299.17.2056. PMID:18460666
   PubMed Web of Science ®Google Scholar
• Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis. 2005;41(6):839-47. doi:10.1086/432804. PMID:16107984
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342(1):15-20. doi:10.1056/NEJM200001063420103. PMID:10620644
   PubMed Web of Science ®Google Scholar
• Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, Mohle-Boetani J, Gershman K, Schaffner W, Petit S, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med. 2009;360(25):2626-36. doi:10.1056/NEJMoa0806820. PMID:19535801
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs): Emerging infections program network. [accessed 2013 Apr 28]. https://www.cdc.gov/abcs/reports-findings/survreports/gbs13.html
   Google Scholar
• Kobayashi M, Vekemans J, Baker CJ, Ratner AJ, Le Doare K, Schrag SJ. Group B Streptococcus vaccine development: Present status and future considerations, with emphasis on perspectives for low and middle income countries. F1000Res. 2016;5:2355. doi:10.12688/f1000research.9363.1. PMID:27803803
   PubMedGoogle Scholar
• Nuccitelli A, Rinaudo CD, Maione D. Group B Streptococcus vaccine: State of the art. Ther Adv Vaccines. 2015;3(3):76-90. doi:10.1177/2051013615579869. PMID:26288735
   PubMedGoogle Scholar
• Kobayashi M, Schrag SJ, Alderson MR, Madhi SA, Baker CJ, Sobanjo-Ter Meulen A, Kaslow DC, Smith PG, Moorthy VS, Vekemans J. WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016. Vaccine. [Epub ahead of print]; doi: 10.1016/j.vaccine.2016.12.029
   Google Scholar
• Song JY, Moseley MA, Burton RL, Nahm MH. Pneumococcal vaccine and opsonic pneumococcal antibody. J Infect Chemother. 2013;19(3):412-25. doi:10.1007/s10156-013-0601-1. PMID:23657429
   PubMed Web of Science ®Google Scholar
• Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist AC, Gershman KA, Vazquez M, Bennett NM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: A matched case-control study. Lancet. 2006;368(9546):1495-502. doi:10.1016/S0140-6736(06)69637-2. PMID:17071283
   PubMed Web of Science ®Google Scholar
• Henckaerts I, Durant N, De Grave D, Schuerman L, Poolman J. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children. Vaccine. 2007;25(13):2518-27. doi:10.1016/j.vaccine.2006.09.029. PMID:17034907
   PubMed Web of Science ®Google Scholar
• Hu BT, Yu X, Jones TR, Kirch C, Harris S, Hildreth SW, Madore DV, Quataert SA. Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae. Clin Diagn Lab Immunol. 2005;12(2):287-95. PMID:15699424
   PubMedGoogle Scholar
• Vidarsson G, Sigurdardottir ST, Gudnason T, Kjartansson S, Kristinsson KG, Ingolfsdottir G, Jonsson S, Valdimarsson H, Schiffman G, Schneerson R, et al. Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine. Infect Immun. 1998;66(6):2866-70. PMID:9596761
   PubMed Web of Science ®Google Scholar
• Burton RL, Nahm MH. Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies. Clin Vaccine Immunol. 2006;13(9):1004-9. doi:10.1128/CVI.00112-06. PMID:16960111
   PubMed Web of Science ®Google Scholar
• Nahm MH, Briles DE, Yu X. Development of a multi-specificity opsonophagocytic killing assay. Vaccine. 2000;18(24):2768-71. doi:10.1016/S0264-410X(00)00044-X. PMID:10781864
   PubMed Web of Science ®Google Scholar
• Schuchat A. Epidemiology of group B streptococcal disease in the United States: Shifting paradigms. Clin Microbiol Rev. 1998;11(3):497-513. PMID:9665980
   PubMed Web of Science ®Google Scholar
• Bhushan R, Anthony BF, Frasch CE. Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent. Infect Immun. 1998;66(12):5848-53. PMID:9826364
   PubMed Web of Science ®Google Scholar
• Chen VL, Avci FY, Kasper DL. A maternal vaccine against group B Streptococcus: Past, present, and future. Vaccine. 2013;31(Suppl 4):D13-19. doi:10.1016/j.vaccine.2012.12.080. PMID:23973342
   PubMed Web of Science ®Google Scholar
• Fabbrini M, Rigat F, Rinaudo CD, Passalaqua I, Khacheh S, Creti R, Baldassarri L, Carboni F, Anderloni G, Rosini R, et al. The protective value of maternal group B Streptococcus antibodies: Quantitative and functional analysis of naturally acquired responses to capsular polysaccharides and pilus proteins in European maternal sera. Clin Infect Dis. 2016;63(6):746-53. doi:10.1093/cid/ciw377. PMID:27402816
   PubMed Web of Science ®Google Scholar
• Heath PT. An update on vaccination against group B streptococcus. Expert Rev Vaccines. 2011;10(5):685-94. doi:10.1586/erv.11.61. PMID:21604988
   PubMed Web of Science ®Google Scholar
• Nanra JS, Buitrago SM, Crawford S, Ng J, Fink PS, Hawkins J, Scully IL, McNeil LK, Aste-Amezaga JM, Cooper D, et al. Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus. Hum Vaccin Immunother. 2013;9(3):480-7. doi:10.4161/hv.23223. PMID:23249887
   PubMed Web of Science ®Google Scholar
• Burton RL, Antonello J, Cooper D, Goldblatt D, Kim KH, Plikaytis BD, Roalfe L, Wauters D, Williams F, Xie GL, et al. Assignment of opsonic values to pneumococcal reference serum 007sp for use in opsonophagocytic assays for 13 serotypes. Clin Vaccine Immunol. 2017;24(2):e00457-16. doi:10.1128/CVI.00457-16. PMID:27974397
   PubMed Web of Science ®Google Scholar
• Burton RL, Nahm MH. Development of a fourfold multiplexed opsonophagocytosis assay for pneumococcal antibodies against additional serotypes and discovery of serological subtypes in Streptococcus pneumoniae serotype 20. Clin Vaccine Immunol. 2012;19(6):835-41. doi:10.1128/CVI.00086-12. PMID:22518015
   PubMed Web of Science ®Google Scholar
• Kim KH, Yu J, Nahm MH. Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies. Clin Diagn Lab Immunol. 2003;10(4):616-21. PMID:12853394
   PubMedGoogle Scholar